Bio Medica Laboratories Limited has launched an Initial Public Offering (IPO). A new issuance and an offer for sale by selling shareholders make up the initial public offering (IPO). The entire amount of the problem is ₹52.43 crore.
Legacy Law Offices provided legal advice and support to Bio Medica Laboratories, the selling shareholders Mr. Mukesh Mehta and Mr. Pradeep Mehta, and the Book running Lead Manager Narnolia Financial Services Ltd, for this IPO.
The transaction was led by Pradyun Chakravarty (Partner) and Naman Anand (Counsel), with assistance from Associates Meghna Shukla and Pallash Pamnani.
Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations. It produces a range of products, including ethical drugs, generic drugs, and over-the-counter (OTC) drugs, primarily in the form of injectables such as Liquid Injections and Dry Powder Injections.